Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report

Purpose. To present the case of a 27-year-old male patient with stage IV proliferative sickle cell retinopathy, treated with one intravitreal injection of ranibizumab, showing regression of the neovascularization and no recurrence at the 9-month follow-up. Methods. A 27-year-old male patient present...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Ophthalmol Med
Hlavní autoři: Mitropoulos, Panagiotis G., Chatziralli, Irini P., Parikakis, Efstratios A., Peponis, Vasileios G., Amariotakis, Georgios A., Moschos, Marilita M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4258923/
https://ncbi.nlm.nih.gov/pubmed/25506450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/682583
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky